Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Olorunsola F. Agbaje"'
Autor:
Moritz J. Hundertmark, Olorunsola F. Agbaje, Ruth Coleman, Jyothis T. George, Rolf Grempler, Rury R. Holman, Hanan Lamlum, Jisoo Lee, Joanne E. Milton, Heiko G. Niessen, Oliver Rider, Christopher T. Rodgers, Ladislav Valkovič, Eleanor Wicks, Masliza Mahmod, Stefan Neubauer
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2580-2590 (2021)
Abstract Aims Despite substantial improvements over the last three decades, heart failure (HF) remains associated with a poor prognosis. The sodium‐glucose co‐transporter‐2 inhibitor empagliflozin demonstrated significant reductions of HF hospi
Externí odkaz:
https://doaj.org/article/70e5e797e27347219ca852428a66c514
Autor:
Chitrabhanu Ballav, Archana Dhere, Irene Kennedy, Olorunsola F. Agbaje, Sarah White, Rachel Franklin, Bolette Hartmann, Jens J. Holst, Rury R. Holman, Katharine R. Owen
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 3, Pp n/a-n/a (2020)
Abstract Aims The GLP1 agonist lixisenatide is glucagonostatic and reduces post‐prandial blood glucose (PPBG) in type 2 diabetes. This study investigates its impact in type 1 diabetes (T1D). Methods In a blinded, crossover trial, 25 patients with T
Externí odkaz:
https://doaj.org/article/de2092e4a2584c289af7a34db2a2de7d
Autor:
Eleanor Wicks, Hanan Lamlum, Jyothis T. George, Olorunsola F. Agbaje, Christopher T. Rodgers, Rury R. Holman, Oliver J Rider, Ladislav Valkovič, Heiko G. Niessen, Rolf Grempler, Stefan Neubauer, Moritz Hundertmark, Joanne E. Milton, Jisoo Lee, Ruth L. Coleman, Masliza Mahmod
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2580-2590 (2021)
ESC Heart Failure
ESC Heart Failure
Aims Despite substantial improvements over the last three decades, heart failure (HF) remains associated with a poor prognosis. The sodium-glucose co-transporter-2 inhibitor empagliflozin demonstrated significant reductions of HF hospitalization in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c963ade06b856a2fa857cae15b1d938c
https://doaj.org/article/70e5e797e27347219ca852428a66c514
https://doaj.org/article/70e5e797e27347219ca852428a66c514
Publikováno v:
The Lancet Diabetes & Endocrinology. 8:206-215
Latent autoimmune diabetes of adulthood (LADA) differs in clinical features from type 2 diabetes. Whether this difference translates into different risks of complications remains controversial. We examined the long-term risk of microvascular complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad7c6a1932a12e256b1290cc97a3e0f
https://doi.org/10.1016/s2213-8587(20)30003-6
https://doi.org/10.1016/s2213-8587(20)30003-6
Autor:
Jeremy Tomlinson, Rury R. Holman, Paul Stewart, Olorunsola F. Agbaje, Anastasia Arvaniti, Riccardo Pofi, Joanne E. Milton, Andrew Whittaker, Nantia Othonos, Ruth L. Coleman
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8652aef708d72b568d063237bfabf1fc
https://doi.org/10.1530/endoabs.70.oc3.6
https://doi.org/10.1530/endoabs.70.oc3.6
Autor:
Olorunsola F. Agbaje, Samiul A. Mostafa, Rury R. Holman, Alastair Gray, Ruth L. Coleman, M A Bethel
Aim Glucose-lowering interventions in Type 2 diabetes mellitus have demonstrated reductions in microvascular complications and modest reductions in macrovascular complications. However, the degree to which targeting different HbA1c reductions might r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63e86fbb701d290952b1e0995706c64
https://doi.org/10.1111/dme.13533
https://doi.org/10.1111/dme.13533
Autor:
Andrew T. Hattersley, Rury R. Holman, Ewan R. Pearson, Angus G. Jones, Beverley M. Shields, Ruth L. Coleman, Olorunsola F. Agbaje
Publikováno v:
Diabetes Research and Clinical Practice. 166:108333
Aims Predicting likely durability of glucose-lowering therapies for people with type 2 diabetes (T2D) could help inform individualised therapeutic choices. Methods We used data from UKPDS patients with newly-diagnosed T2D randomised to first-line glu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b54b0170ee4bde4dc624e0e0b8c2d3
https://doi.org/10.1016/j.diabres.2020.108333
https://doi.org/10.1016/j.diabres.2020.108333
Autor:
Samiul A. Mostafa, Alastair Gray, Ruth L. Coleman, Rury R. Holman, Olorunsola F. Agbaje, M A Bethel
Publikováno v:
Journal of Diabetes and Its Complications. 33(1)
Aims There are few data available on the incremental benefits of risk factor modification in type 2 diabetes mellitus (T2DM). We simulated the potential benefits of achieving lower systolic blood pressure (SBP) and LDL-cholesterol targets. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa32c55b819ea4e0904d1bc600d623a
http://ora.ox.ac.uk/objects/uuid:
http://ora.ox.ac.uk/objects/uuid:
Autor:
Aliki Taylor, Hans Garmo, S. Kabilan, Olorunsola F. Agbaje, Arnie Purushotham, Mark Harries, Lars Holmberg
Publikováno v:
Cancer Epidemiology. 38:427-434
Bone is the most common metastatic site associated with breast cancer. Using a database of women with breast cancer treated at Guy's Hospital, London 1976-2006 and followed until end 2010, we determined incidence of and survival after bone metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734bd8133bd0303a1ed17c900888fde7
https://doi.org/10.1016/j.canep.2014.05.005
https://doi.org/10.1016/j.canep.2014.05.005
Autor:
Salena Bains, Hisham Hamed, Ian S. Fentiman, Olorunsola F. Agbaje, Michael Douek, Sarah E Pinder, Amalinda Suyoi, Ash Kothari, Arnie Purushotham
Publikováno v:
European Journal of Cancer. 50:690-697
Background The management of the axilla in the presence of positive sentinel lymph node (SLN) remains controversial. Many centres forgo completion axillary lymph node dissection (cALND) in the presence of micrometastatic disease. The American College
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47f91838e5f74b044a26dae9658ed936
https://doi.org/10.1016/j.ejca.2013.11.024
https://doi.org/10.1016/j.ejca.2013.11.024